T94	ZeroArticleNP 0 10	Drug Label
T95	ZeroArticleNP 15 34	drug brand TAMBOCOR
T96	DefiniteNP 317 335	the cardiac rhythm
T97	IndefiniteNP 237 253	a left hemiblock
T98	IndefiniteNP 283 294	a pacemaker
T99	DefiniteNP 407 419	the presence
T100	DefiniteNP 470 478	the drug
T101	DefiniteNP 528 551	the National Heart Lung
T102	IndefiniteNP 758 781	a myocardial infarction
T103	IndefiniteNP 837 859	An excessive mortality
T104	IndefiniteNP 984 1025	a carefully matched placebo-treated group
T105	DefiniteNP 1089 1108	the matched placebo
T106	DemonstrativeNP 1027 1036	This rate
T107	DefiniteNP 1110 1130	The average duration
T108	DemonstrativeNP 1161 1171	this study
T109	PersonalPronoun 1328 1330	it
T110	DefiniteNP 1188 1205	The applicability
T111	DefiniteNP 1209 1217	the CAST
T112	DefiniteNP 1354 1487	the risks of Class IC agents (including TAMBOCOR), coupled with the lack of any evidence of improved survival, generally unacceptable
T113	DefiniteNP 1558 1570	the patients
T114	IndefiniteNP 1229 1246	other populations
T115	DefiniteNP 1738 1758	the world literature
T116	IndefiniteNP 1726 1734	A review
T117	DemonstrativeNP 1928 1942	these patients
T118	DefiniteNP 1962 1976	the literature
T119	PersonalPronoun 2345 2346	I
T120	DefiniteNP 2476 2491	the atrial rate
T121	IndefiniteNP 2333 2344	other Class
T122	ZeroArticleNP 2347 2353	agents
T123	DefiniteNP 2519 2539	the ventricular rate
T124	IndefiniteNP 2493 2515	A paradoxical increase
T125	DefiniteNP 2699 2707	the risk
T126	DemonstrativeNP 2711 2728	this complication
T127	ZeroArticleNP 2614 2655	Concomitant negative chronotropic therapy
T128	ZeroArticleNP 2818 2840	digitalis preparations
T129	ZeroArticleNP 2844 2875	beta-adrenergic blocking agents
T130	IndefiniteNP 2992 3010	a maintenance dose
T131	IndefiniteNP 3023 3043	a 13% - 19% increase
T132	IndefiniteNP 3104 3111	a study
T133	DistributivePronoun 3378 3382	each
T134	DefiniteNP 3430 3439	the drugs
T135	DefiniteNP 3468 3479	the effects
T136	DemonstrativeNP 3317 3346	this formal interaction study
T137	DefiniteNP 3495 3506	The effects
T138	DefiniteNP 3568 3583	the PR interval
T139	IndefiniteNP 3712 3734	an increased incidence
T140	ZeroArticleNP 3666 3679	beta blockers
T141	DefiniteNP 3766 3781	the possibility
T142	ZeroArticleNP 3824 3837	beta blockers
T143	DistributivePronoun 4080 4086	either
T144	DefiniteNP 4019 4029	the extent
T145	ZeroArticleNP 3953 3966	several drugs
T146	IndefiniteNP 4152 4163	other drugs
T147	ZeroArticleNP 4202 4216	anticoagulants
T148	IndefiniteNP 4268 4282	a large number
T149	ZeroArticleNP 4305 4314	diuretics
T150	DefiniteNP 4477 4485	the rate
T151	IndefiniteNP 4459 4473	a 30% increase
T152	ZeroArticleNP 4380 4401	known enzyme inducers
T153	IndefiniteNP 4773 4786	some patients
T154	ZeroArticleNP 4695 4713	flecainide therapy
T155	DefiniteNP 4932 4957	the plasma concentrations
T156	DemonstrativeNP 5038 5052	these patients
T157	ZeroArticleNP 4858 4896	Drugs that inhibit cytochrome P450IID6
T158	ZeroArticleNP 4996 5022	chronic flecainide therapy
T159	DefiniteNP 5119 5139	the coadministration
T160	DistributivePronoun 5198 5202	both
T161	DefiniteNP 5257 5268	the effects
T162	DefiniteNP 5412 5424	the judgment
T163	DefiniteNP 5428 5441	the physician
T164	DefiniteNP 5443 5455	the benefits
T165	DefiniteNP 5485 5494	the risks
T166	DemonstrativeNP 5206 5217	these drugs
T167	DemonstrativeNP 5459 5475	this combination
T168	DistributiveNP 5316 5336	neither disopyramide
T169	DefiniteNP 5538 5558	the coadministration
T170	IndefiniteNP 5781 5822	any compound-related carcinogenic effects
T171	IndefiniteNP 5913 5934	any mutagenic effects
T172	DefiniteNP 6002 6022	the usual human dose
T173	IndefiniteNP 5936 5960	A rat reproduction study
T174	IndefiniteNP 6039 6057	any adverse effect
T175	IndefiniteNP 6278 6299	an embryotoxic effect
T176	IndefiniteNP 6419 6432	another breed
T177	DefiniteNP 6673 6686	the high dose
T178	DefiniteNP 6822 6843	the potential benefit
T179	DefiniteNP 6854 6872	the potential risk
T180	DefiniteNP 6876 6885	the fetus
T181	PersonalPronoun 6907 6909	It
T182	DefiniteNP 6931 6938	the use
T183	DefiniteNP 7020 7030	the mother
T184	DefiniteNP 7049 7061	the duration
T185	DefiniteNP 7097 7112	the possibility
T186	IndefiniteNP 7136 7166	other obstetrical intervention
T187	DefiniteNP 7460 7467	the top
T188	DefiniteNP 7471 7492	the therapeutic range
T189	DefiniteNP 7503 7528	the calculated daily dose
T190	IndefiniteNP 7198 7219	a multiple dose study
T191	IndefiniteNP 7433 7456	a maternal plasma level
T192	IndefiniteNP 7532 7548	a nursing infant
T193	DefiniteNP 7639 7649	The safety
T194	DefiniteNP 7678 7687	the fetus
T195	DefiniteNP 8042 8064	the potential benefits
T196	DefiniteNP 8082 8091	the risks
T197	DemonstrativeNP 8021 8034	such patients
T2	Drug 3054 3061	digoxin
T3	Drug 2935 2957	oral doses of TAMBOCOR
T7	Drug 3242 3253	propranolol
T8	Drug 3149 3157	TAMBOCOR
T9	Drug 3162 3173	propranolol
T13	Drug 3348 3356	TAMBOCOR
T14	Drug 3361 3372	propranolol
T16	Drug_Class 3824 3837	beta blockers
T17	Drug 3842 3852	flecainide
T19	Drug 4489 4499	flecainide
T20	Drug_Class 4386 4401	enzyme inducers
T21	Drug 4403 4412	phenytoin
T22	Drug 4414 4427	phenobarbital
T23	Drug 4429 4442	carbamazepine
T25	Drug 4588 4598	flecainide
T27	Drug 4543 4553	cimetidine
T29	Drug 4722 4732	flecainide
T30	Drug 4672 4682	amiodarone
T32	Drug_Class 4858 4896	Drugs that inhibit cytochrome P450IID6
T33	Drug 4906 4915	quinidine
T34	Drug 4961 4971	flecainide
T36	Drug 5392 5400	TAMBOCOR
T37	Drug 5324 5336	disopyramide
T38	Drug 5341 5350	verapamil
T39	Drug_Class 2844 2875	beta-adrenergic blocking agents
T40	Drug_Class 3666 3679	beta blockers
T41	Drug 5179 5188	verapamil
T42	Drug 3553 3564	propranolol
T43	Drug 2664 2671	digoxin
T44	Drug 3014 3021	digoxin
T45	Drug 5576 5586	nifedipine
T46	Drug 5590 5599	diltiazem
T47	Drug_Class 4305 4314	diuretics
T48	Drug_Class 2675 2688	beta-blockers
T49	Drug 2818 2827	digitalis
T50	Drug 47 57	flecainide
T51	Drug 2049 2059	FLECAINIDE
T52	Drug 3875 3885	Flecainide
T53	Drug 4033 4043	flecainide
T54	Drug 4695 4705	flecainide
T55	Drug 4791 4801	flecainide
T56	Drug 5004 5014	flecainide
T57	Drug 5707 5717	flecainide
T58	Drug 6120 6130	Flecainide
T59	Drug 7276 7286	flecainide
T60	Drug 7883 7893	flecainide
T61	Drug 5163 5175	disopyramide
T62	Drug_Class 4202 4216	anticoagulants
T63	Drug 26 34	TAMBOCOR
T64	Drug 90 98	TAMBOCOR
T65	Drug 371 379	TAMBOCOR
T66	Drug 503 511	TAMBOCOR
T67	Drug 927 935	TAMBOCOR
T68	Drug 1059 1067	TAMBOCOR
T69	Drug 1149 1157	TAMBOCOR
T70	Drug 1394 1402	TAMBOCOR
T71	Drug 1810 1818	TAMBOCOR
T72	Drug 2208 2216	TAMBOCOR
T73	Drug 2377 2385	TAMBOCOR
T74	Drug 2604 2612	TAMBOCOR
T75	Drug 2765 2773	TAMBOCOR
T76	Drug 3540 3548	TAMBOCOR
T77	Drug 3612 3620	TAMBOCOR
T78	Drug 4242 4250	TAMBOCOR
T79	Drug 5143 5151	TAMBOCOR
T80	Drug 5294 5302	TAMBOCOR
T81	Drug 5562 5570	TAMBOCOR
T82	Drug 6773 6781	TAMBOCOR
T83	Drug 6942 6950	TAMBOCOR
T84	Drug 7666 7674	TAMBOCOR
T85	Drug 7990 7998	TAMBOCOR
R12	Appositive Attribute:T152 Head:T21
R13	Appositive Attribute:T152 Head:T23
R14	Appositive Attribute:T152 Head:T22
R15	Anaphora Anaphor:T100 Antecedent:T65
R16	Anaphora Anaphor:T133 Antecedent:T13
R17	Anaphora Anaphor:T133 Antecedent:T14
R18	Anaphora Anaphor:T134 Antecedent:T13
R19	Anaphora Anaphor:T134 Antecedent:T14
R20	Anaphora Anaphor:T143 Antecedent:T16
R21	Anaphora Anaphor:T143 Antecedent:T53
R22	Anaphora Anaphor:T160 Antecedent:T61
R23	Anaphora Anaphor:T160 Antecedent:T41
R24	Anaphora Anaphor:T166 Antecedent:T61
R25	Anaphora Anaphor:T166 Antecedent:T41
R26	Anaphora Anaphor:T167 Antecedent:T168
